[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fH2mQYKkL9woQ5CTNXb7qtDfwo9hGYSrZirI70ygoEAQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":65,"rows":72},"Pusan National University Yangsan Hospital",[4],104,false,31,1,14118,9,85,[14,17,20,23,25,28,30,33],{"name":15,"count":16},"Stroke",7,{"name":18,"count":19},"Spinal Cord Injuries",5,{"name":21,"count":22},"Remimazolam",4,{"name":24,"count":22},"Sarcopenia",{"name":26,"count":27},"Coronary Artery Disease",3,{"name":29,"count":27},"Muscular Sarcoidosis",{"name":31,"count":32},"Lung Transplantation",2,{"name":34,"count":32},"Subjective Memory Impairment",[36,41,46,51,56,60],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT06711978","Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors","2025-05-31","Mirogabalin",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT06907823","Comparison of Sevoflurane and Propofol on ANI","2025-12-31","propofol",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT05939674","Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam","2026-02","Flumazenil",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT07511634","Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Controlled Study","2026-12-31","Desflurane",{"nctId":57,"briefTitle":58,"date":59,"intervention":21},"NCT07620782","Response Surface Modeling of Remimazolam and Sevoflurane","2027-04-01",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT07060443","Fluorescence Lymph Node Mapping for Colon Cancer Surgery","2028-12-31","Indocyanine green (ICG) injection for intraoperative lymph node imaging",[66,67,68,69,70,71],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[73,97,146,198,220,245,263,281,304,322,349,367,394,412,438,464,482,500,526,544,569,597,623,641,659,684],{"intervention":64,"totalTrials":9,"cells":74},{"EARLY_PHASE1":75,"PHASE1":78,"PHASE2":80,"PHASE3":91,"PHASE4":93,"NA":95},{"trials":76,"activeCount":77},[],0,{"trials":79,"activeCount":77},[],{"trials":81,"activeCount":9,"soonestReadout":63},[82],{"nctId":61,"briefTitle":62,"status":83,"phases":84,"primaryCompletion":63,"completion":85,"start":86,"enrollment":87,"conditions":88,"interventions":90},"RECRUITING",[68],"2030-12-31","2025-07-23",186,[89],"Right Hemicolectomy",[64],{"trials":92,"activeCount":77},[],{"trials":94,"activeCount":77},[],{"trials":96,"activeCount":77},[],{"intervention":98,"totalTrials":22,"cells":99},"Sevoflurane",{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":121},{"trials":101,"activeCount":77},[],{"trials":103,"activeCount":77},[],{"trials":105,"activeCount":77},[],{"trials":107,"activeCount":77},[],{"trials":109,"activeCount":77},[110],{"nctId":111,"briefTitle":112,"status":113,"phases":114,"primaryCompletion":115,"completion":115,"start":116,"enrollment":117,"conditions":118,"interventions":120},"NCT02301676","Long Term Postoperative Cognitive Dysfunction in the Elderly Patients","UNKNOWN",[70],"2016-12","2014-12",190,[119],"Cognitive Impairment",[98,45],{"trials":122,"activeCount":27,"soonestReadout":44},[123,131,139],{"nctId":52,"briefTitle":53,"status":124,"phases":125,"primaryCompletion":54,"completion":54,"start":126,"enrollment":127,"conditions":128,"interventions":130},"NOT_YET_RECRUITING",[71],"2026-04-01",80,[129],"General Anesthesia",[55,98],{"nctId":42,"briefTitle":43,"status":124,"phases":132,"primaryCompletion":44,"completion":44,"start":133,"enrollment":134,"conditions":135,"interventions":138},[71],"2025-06-30",30,[136,98,137],"Propofol","Analgesia Nociception Index",[45,98],{"nctId":57,"briefTitle":58,"status":83,"phases":140,"primaryCompletion":59,"completion":141,"start":142,"enrollment":127,"conditions":143,"interventions":145},[71],"2027-12-31","2026-05-15",[144],"Laparoscopic Surgery",[21,98],{"intervention":21,"totalTrials":22,"cells":147},{"EARLY_PHASE1":148,"PHASE1":150,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":158},{"trials":149,"activeCount":77},[],{"trials":151,"activeCount":77},[],{"trials":153,"activeCount":77},[],{"trials":155,"activeCount":77},[],{"trials":157,"activeCount":77},[],{"trials":159,"activeCount":9,"soonestReadout":59},[160,171,183,194],{"nctId":161,"briefTitle":162,"status":163,"phases":164,"primaryCompletion":165,"completion":133,"start":166,"enrollment":167,"conditions":168,"interventions":170},"NCT06385002","Effect of Combined Administration of Sevoflurane and Remimazolam on Emergence","COMPLETED",[71],"2024-08-31","2023-07-31",146,[169],"Gynecological Surgery",[21],{"nctId":172,"briefTitle":173,"status":163,"phases":174,"primaryCompletion":175,"completion":175,"start":176,"enrollment":177,"conditions":178,"interventions":181},"NCT05907525","Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation",[71],"2024-04-15","2023-06-29",66,[179,180,21],"One-Lung Ventilation","Thoracic Surgery, Video-Assisted",[21,182],"1% propofol",{"nctId":184,"briefTitle":185,"status":113,"phases":186,"primaryCompletion":187,"completion":187,"start":188,"enrollment":189,"conditions":190,"interventions":192},"NCT05935657","The Effect of Remimazolam and Dexmedetomidine on the Incidence of Hypotension During Spinal Anesthesia",[71],"2024-06","2023-08",72,[21,191],"Spinal Anesthesia",[21,193],"Dexmedetomidine",{"nctId":57,"briefTitle":58,"status":83,"phases":195,"primaryCompletion":59,"completion":141,"start":142,"enrollment":127,"conditions":196,"interventions":197},[71],[144],[21,98],{"intervention":45,"totalTrials":32,"cells":199},{"EARLY_PHASE1":200,"PHASE1":202,"PHASE2":204,"PHASE3":206,"PHASE4":208,"NA":214},{"trials":201,"activeCount":77},[],{"trials":203,"activeCount":77},[],{"trials":205,"activeCount":77},[],{"trials":207,"activeCount":77},[],{"trials":209,"activeCount":77},[210],{"nctId":111,"briefTitle":112,"status":113,"phases":211,"primaryCompletion":115,"completion":115,"start":116,"enrollment":117,"conditions":212,"interventions":213},[70],[119],[98,45],{"trials":215,"activeCount":9,"soonestReadout":44},[216],{"nctId":42,"briefTitle":43,"status":124,"phases":217,"primaryCompletion":44,"completion":44,"start":133,"enrollment":134,"conditions":218,"interventions":219},[71],[136,98,137],[45,98],{"intervention":50,"totalTrials":9,"cells":221},{"EARLY_PHASE1":222,"PHASE1":224,"PHASE2":226,"PHASE3":228,"PHASE4":230,"NA":232},{"trials":223,"activeCount":77},[],{"trials":225,"activeCount":77},[],{"trials":227,"activeCount":77},[],{"trials":229,"activeCount":77},[],{"trials":231,"activeCount":77},[],{"trials":233,"activeCount":9,"soonestReadout":49},[234],{"nctId":47,"briefTitle":48,"status":83,"phases":235,"primaryCompletion":49,"completion":236,"start":237,"enrollment":238,"conditions":239,"interventions":243},[71],"2026-06","2023-09-19",24,[240,21,241,242],"Flumazenil Adverse Reaction","Hip Joint","Elderly Patients",[50,244],"normal saline",{"intervention":244,"totalTrials":9,"cells":246},{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":255,"NA":257},{"trials":248,"activeCount":77},[],{"trials":250,"activeCount":77},[],{"trials":252,"activeCount":77},[],{"trials":254,"activeCount":77},[],{"trials":256,"activeCount":77},[],{"trials":258,"activeCount":9,"soonestReadout":49},[259],{"nctId":47,"briefTitle":48,"status":83,"phases":260,"primaryCompletion":49,"completion":236,"start":237,"enrollment":238,"conditions":261,"interventions":262},[71],[240,21,241,242],[50,244],{"intervention":55,"totalTrials":9,"cells":264},{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":275},{"trials":266,"activeCount":77},[],{"trials":268,"activeCount":77},[],{"trials":270,"activeCount":77},[],{"trials":272,"activeCount":77},[],{"trials":274,"activeCount":77},[],{"trials":276,"activeCount":9,"soonestReadout":54},[277],{"nctId":52,"briefTitle":53,"status":124,"phases":278,"primaryCompletion":54,"completion":54,"start":126,"enrollment":127,"conditions":279,"interventions":280},[71],[129],[55,98],{"intervention":40,"totalTrials":9,"cells":282},{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":289,"PHASE4":291,"NA":293},{"trials":284,"activeCount":77},[],{"trials":286,"activeCount":77},[],{"trials":288,"activeCount":77},[],{"trials":290,"activeCount":77},[],{"trials":292,"activeCount":77},[],{"trials":294,"activeCount":9,"soonestReadout":39},[295],{"nctId":37,"briefTitle":38,"status":124,"phases":296,"primaryCompletion":39,"completion":133,"start":297,"enrollment":177,"conditions":298,"interventions":303},[71],"2024-12-01",[299,300,301,302,40],"CIPN","CIPN - Chemotherapy-Induced Peripheral Neuropathy","CIPN in Adjuvant Breast Cancer Patients","Duloxetine",[40,302],{"intervention":302,"totalTrials":9,"cells":305},{"EARLY_PHASE1":306,"PHASE1":308,"PHASE2":310,"PHASE3":312,"PHASE4":314,"NA":316},{"trials":307,"activeCount":77},[],{"trials":309,"activeCount":77},[],{"trials":311,"activeCount":77},[],{"trials":313,"activeCount":77},[],{"trials":315,"activeCount":77},[],{"trials":317,"activeCount":9,"soonestReadout":39},[318],{"nctId":37,"briefTitle":38,"status":124,"phases":319,"primaryCompletion":39,"completion":133,"start":297,"enrollment":177,"conditions":320,"interventions":321},[71],[299,300,301,302,40],[40,302],{"intervention":323,"totalTrials":9,"cells":324},"Sugammadex Injection [Bridion]",{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":329,"PHASE3":331,"PHASE4":333,"NA":347},{"trials":326,"activeCount":77},[],{"trials":328,"activeCount":77},[],{"trials":330,"activeCount":77},[],{"trials":332,"activeCount":77},[],{"trials":334,"activeCount":77},[335],{"nctId":336,"briefTitle":337,"status":163,"phases":338,"primaryCompletion":339,"completion":340,"start":341,"enrollment":342,"conditions":343,"interventions":345},"NCT03229486","Effect of Sugammadex vs. Neostigmine\u002FGlycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia",[70],"2019-07-30","2019-12-30","2017-03-01",40,[344],"Emergence Delirium",[323,346],"Neostigmine+Glycopyrronium",{"trials":348,"activeCount":77},[],{"intervention":346,"totalTrials":9,"cells":350},{"EARLY_PHASE1":351,"PHASE1":353,"PHASE2":355,"PHASE3":357,"PHASE4":359,"NA":365},{"trials":352,"activeCount":77},[],{"trials":354,"activeCount":77},[],{"trials":356,"activeCount":77},[],{"trials":358,"activeCount":77},[],{"trials":360,"activeCount":77},[361],{"nctId":336,"briefTitle":337,"status":163,"phases":362,"primaryCompletion":339,"completion":340,"start":341,"enrollment":342,"conditions":363,"interventions":364},[70],[344],[323,346],{"trials":366,"activeCount":77},[],{"intervention":368,"totalTrials":9,"cells":369},"Dihydroxydibutylether group",{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":378,"NA":392},{"trials":371,"activeCount":77},[],{"trials":373,"activeCount":77},[],{"trials":375,"activeCount":77},[],{"trials":377,"activeCount":77},[],{"trials":379,"activeCount":77},[380],{"nctId":381,"briefTitle":382,"status":163,"phases":383,"primaryCompletion":384,"completion":385,"start":386,"enrollment":387,"conditions":388,"interventions":390},"NCT05199441","Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia",[70],"2023-07-05","2023-07-07","2022-02-25",226,[389],"Dyspepsia",[368,391],"Control group placebo",{"trials":393,"activeCount":77},[],{"intervention":391,"totalTrials":9,"cells":395},{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":402,"PHASE4":404,"NA":410},{"trials":397,"activeCount":77},[],{"trials":399,"activeCount":77},[],{"trials":401,"activeCount":77},[],{"trials":403,"activeCount":77},[],{"trials":405,"activeCount":77},[406],{"nctId":381,"briefTitle":382,"status":163,"phases":407,"primaryCompletion":384,"completion":385,"start":386,"enrollment":387,"conditions":408,"interventions":409},[70],[389],[368,391],{"trials":411,"activeCount":77},[],{"intervention":413,"totalTrials":9,"cells":414},"Peginterferon alfa-2a and Ribavirin",{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":421,"PHASE4":423,"NA":436},{"trials":416,"activeCount":77},[],{"trials":418,"activeCount":77},[],{"trials":420,"activeCount":77},[],{"trials":422,"activeCount":77},[],{"trials":424,"activeCount":77},[425],{"nctId":426,"briefTitle":427,"status":113,"phases":428,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":433,"interventions":435},"NCT01056172","PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)",[70],"2012-06","2012-12","2010-01",164,[434],"Chronic Hepatitis C",[413,413],{"trials":437,"activeCount":77},[],{"intervention":439,"totalTrials":9,"cells":440},"Telbivudine",{"EARLY_PHASE1":441,"PHASE1":443,"PHASE2":445,"PHASE3":447,"PHASE4":449,"NA":462},{"trials":442,"activeCount":77},[],{"trials":444,"activeCount":77},[],{"trials":446,"activeCount":77},[],{"trials":448,"activeCount":77},[],{"trials":450,"activeCount":77},[451],{"nctId":452,"briefTitle":453,"status":113,"phases":454,"primaryCompletion":455,"completion":116,"start":456,"enrollment":6,"conditions":457,"interventions":459},"NCT01588912","Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir",[70],"2013-12","2012-04",[458],"Chronic Hepatitis B",[439,460,461],"Tenofovir","Entecavir",{"trials":463,"activeCount":77},[],{"intervention":460,"totalTrials":9,"cells":465},{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":474,"NA":480},{"trials":467,"activeCount":77},[],{"trials":469,"activeCount":77},[],{"trials":471,"activeCount":77},[],{"trials":473,"activeCount":77},[],{"trials":475,"activeCount":77},[476],{"nctId":452,"briefTitle":453,"status":113,"phases":477,"primaryCompletion":455,"completion":116,"start":456,"enrollment":6,"conditions":478,"interventions":479},[70],[458],[439,460,461],{"trials":481,"activeCount":77},[],{"intervention":461,"totalTrials":9,"cells":483},{"EARLY_PHASE1":484,"PHASE1":486,"PHASE2":488,"PHASE3":490,"PHASE4":492,"NA":498},{"trials":485,"activeCount":77},[],{"trials":487,"activeCount":77},[],{"trials":489,"activeCount":77},[],{"trials":491,"activeCount":77},[],{"trials":493,"activeCount":77},[494],{"nctId":452,"briefTitle":453,"status":113,"phases":495,"primaryCompletion":455,"completion":116,"start":456,"enrollment":6,"conditions":496,"interventions":497},[70],[458],[439,460,461],{"trials":499,"activeCount":77},[],{"intervention":501,"totalTrials":9,"cells":502},"Tirofiban",{"EARLY_PHASE1":503,"PHASE1":505,"PHASE2":507,"PHASE3":509,"PHASE4":522,"NA":524},{"trials":504,"activeCount":77},[],{"trials":506,"activeCount":77},[],{"trials":508,"activeCount":77},[],{"trials":510,"activeCount":77},[511],{"nctId":512,"briefTitle":513,"status":113,"phases":514,"primaryCompletion":515,"completion":515,"start":516,"enrollment":517,"conditions":518,"interventions":520},"NCT01660373","Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome",[69],"2013-08","2012-08",100,[519],"Non-ST Segment Elevation Acute Coronary Syndrome",[501,521],"Ticagrelor",{"trials":523,"activeCount":77},[],{"trials":525,"activeCount":77},[],{"intervention":521,"totalTrials":9,"cells":527},{"EARLY_PHASE1":528,"PHASE1":530,"PHASE2":532,"PHASE3":534,"PHASE4":540,"NA":542},{"trials":529,"activeCount":77},[],{"trials":531,"activeCount":77},[],{"trials":533,"activeCount":77},[],{"trials":535,"activeCount":77},[536],{"nctId":512,"briefTitle":513,"status":113,"phases":537,"primaryCompletion":515,"completion":515,"start":516,"enrollment":517,"conditions":538,"interventions":539},[69],[519],[501,521],{"trials":541,"activeCount":77},[],{"trials":543,"activeCount":77},[],{"intervention":545,"totalTrials":9,"cells":546},"Ketamine",{"EARLY_PHASE1":547,"PHASE1":549,"PHASE2":551,"PHASE3":563,"PHASE4":565,"NA":567},{"trials":548,"activeCount":77},[],{"trials":550,"activeCount":77},[],{"trials":552,"activeCount":77},[553],{"nctId":554,"briefTitle":555,"status":113,"phases":556,"primaryCompletion":557,"completion":557,"start":558,"enrollment":559,"conditions":560,"interventions":562},"NCT03362073","Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients",[68],"2021-12-31","2018-06-01",26,[545,561],"Refractory Cancer Pain",[545],{"trials":564,"activeCount":77},[],{"trials":566,"activeCount":77},[],{"trials":568,"activeCount":77},[],{"intervention":570,"totalTrials":9,"cells":571},"dose dense MVAC with pegylated GCSF",{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":591,"PHASE4":593,"NA":595},{"trials":573,"activeCount":77},[],{"trials":575,"activeCount":77},[],{"trials":577,"activeCount":77},[578],{"nctId":579,"briefTitle":580,"status":113,"phases":581,"primaryCompletion":582,"completion":583,"start":584,"enrollment":585,"conditions":586,"interventions":590},"NCT04047693","Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma",[68],"2022-01-31","2022-10-31","2019-05-01",32,[587,588,589],"Muscle Invasive Bladder Cancer","Urothelial Carcinoma","Neoadjuvant Chemotherapy",[570],{"trials":592,"activeCount":77},[],{"trials":594,"activeCount":77},[],{"trials":596,"activeCount":77},[],{"intervention":598,"totalTrials":9,"cells":599},"Intravenous infusion of ramosetron",{"EARLY_PHASE1":600,"PHASE1":602,"PHASE2":604,"PHASE3":606,"PHASE4":608,"NA":610},{"trials":601,"activeCount":77},[],{"trials":603,"activeCount":77},[],{"trials":605,"activeCount":77},[],{"trials":607,"activeCount":77},[],{"trials":609,"activeCount":77},[],{"trials":611,"activeCount":77},[612],{"nctId":613,"briefTitle":614,"status":163,"phases":615,"primaryCompletion":616,"completion":115,"start":617,"enrollment":618,"conditions":619,"interventions":622},"NCT02509143","Acupuncture for Postoperative Nausea and Vomiting in Patients Undergoing Colorectal Surgery",[71],"2016-11","2015-07",60,[620,621],"Postoperative Nausea and Vomiting","Colorectal Neoplasms",[598],{"intervention":182,"totalTrials":9,"cells":624},{"EARLY_PHASE1":625,"PHASE1":627,"PHASE2":629,"PHASE3":631,"PHASE4":633,"NA":635},{"trials":626,"activeCount":77},[],{"trials":628,"activeCount":77},[],{"trials":630,"activeCount":77},[],{"trials":632,"activeCount":77},[],{"trials":634,"activeCount":77},[],{"trials":636,"activeCount":77},[637],{"nctId":172,"briefTitle":173,"status":163,"phases":638,"primaryCompletion":175,"completion":175,"start":176,"enrollment":177,"conditions":639,"interventions":640},[71],[179,180,21],[21,182],{"intervention":193,"totalTrials":9,"cells":642},{"EARLY_PHASE1":643,"PHASE1":645,"PHASE2":647,"PHASE3":649,"PHASE4":651,"NA":653},{"trials":644,"activeCount":77},[],{"trials":646,"activeCount":77},[],{"trials":648,"activeCount":77},[],{"trials":650,"activeCount":77},[],{"trials":652,"activeCount":77},[],{"trials":654,"activeCount":77},[655],{"nctId":184,"briefTitle":185,"status":113,"phases":656,"primaryCompletion":187,"completion":187,"start":188,"enrollment":189,"conditions":657,"interventions":658},[71],[21,191],[21,193],{"intervention":660,"totalTrials":9,"cells":661},"Remimazolam besylate",{"EARLY_PHASE1":662,"PHASE1":664,"PHASE2":666,"PHASE3":668,"PHASE4":670,"NA":672},{"trials":663,"activeCount":77},[],{"trials":665,"activeCount":77},[],{"trials":667,"activeCount":77},[],{"trials":669,"activeCount":77},[],{"trials":671,"activeCount":77},[],{"trials":673,"activeCount":77},[674],{"nctId":675,"briefTitle":676,"status":163,"phases":677,"primaryCompletion":678,"completion":678,"start":176,"enrollment":679,"conditions":680,"interventions":682},"NCT05864625","Comparison of Hemodynamic Stability During Anesthesia Using Remimazolam and Sevoflurane in Minimally Invasive AVR",[71],"2025-06-10",64,[681,21],"Aortic Valve Stenosis",[660,683],"Propofol\u002F Sevoflurane",{"intervention":683,"totalTrials":9,"cells":685},{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":692,"PHASE4":694,"NA":696},{"trials":687,"activeCount":77},[],{"trials":689,"activeCount":77},[],{"trials":691,"activeCount":77},[],{"trials":693,"activeCount":77},[],{"trials":695,"activeCount":77},[],{"trials":697,"activeCount":77},[698],{"nctId":675,"briefTitle":676,"status":163,"phases":699,"primaryCompletion":678,"completion":678,"start":176,"enrollment":679,"conditions":700,"interventions":701},[71],[681,21],[660,683]]